Dr. Dudley has applied for patents: (1) Method for Predicting Onset/Risk of Atrial Fibrillation, (2) Prevention of sudden death by modulation of Src family, (3) Modulating mitochondrial reactive oxygen species to increase cardiac sodium channel current and mitigate sudden death, (4) Biomarkers for Prediction of Stroke Risk in Atrial Fibrillation, and (5) Mitochondrial anti-oxidants for prevention of sudden death by raising connexin43 levels. Here, SRC is linked to atrial fibrillation.